MedTrace Logo

Implementation and Outcome of Minimally Invasive Pancreatoduodenectomy in Europe:

NCT06135233 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1336

Last updated 2023-11-18

No results posted yet for this study

Summary

A planned analysis of outcomes among consecutive patients after MIPD from centers participating in the E-MIPS registry (2019-2021). Main outcomes of interest were major morbidity (Clavien-Dindo grade ≥3) and 30-day/in-hospital mortality.

Conditions

  • Pancreas Disease

Interventions

OTHER

No intervention

all patients undergoing minimally invasive pancreatic surgery, no intervention, no randomization

Sponsors & Collaborators

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2021-12-31
Completion
2022-01-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06135233 on ClinicalTrials.gov